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Anaplasma phagocytophilum (Ap), the agent of the tick-borne disease human granulocytic anaplasmosis, is an obligate intracellular pathogen
unique in its ability to target and replicate within neutrophils. It profoundly inhibits neutrophil apoptosis, prolonging neutrophil survival from
hours to days. To determine the basis of antiapoptosis, we compared gene expression in Ap-infected vs mock-infected human neutrophils.
Antiapoptosis genes were consistently and significantly up-regulated (2- to 15-fold) within 1–3 h. These genes synergistically inhibit apoptosis
through several interconnected pathways, including p38MAPK (MAP2K3), ERK (IER3), PI3K (PRKCD), and NF-κB (BCL2A1, NFKB1,
NFKBIA, GADD45B). Both extrinsic death receptor (TNFAIP3, CFLAR, SOD2) and intrinsic mitochondrial (BCL2A1, PIM2, BIRC3) pathways
were affected as confirmed by reductions in both caspase 3 and caspase 8 activities. Several important antiapoptotic genes noted to be up-regulated
in Ap-infected neutrophils were not up-regulated during Ap infection of HL-60 cells (which is not antiapoptotic). In conclusion, just as apoptosis
may be triggered through multiple molecular pathways, effective antiapoptosis of neutrophils is achieved rapidly and redundantly by this
intracellular pathogen dependent on cell survival.
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zoonosis caused by Anaplasma phagocytophilum (Ap), an
obligate gram-negative intracellular pathogen unique in its
ability to target and replicate within granulocytes [1,2]. Ap
replicates within vacuoles to form microcolonies (morulae) that
do not fuse with lysosomes [3]. Without Ap infection,
neutrophils undergo rapid spontaneous apoptosis both in vitro
and in vivo [4,5]. Ap infection delays neutrophil apoptosis in a
dose-dependent manner, facilitating intracellular replication and
survival [6].
Apoptosis can be initiated by extrinsic (death receptor) and
intrinsic (mitochondrial) pathways. In the extrinsic pathway,
ligation of a death receptor such as Fas or TNFR1 induces
formation of a death-inducing signaling complex (DISC)
composed of the death receptor, an adaptor protein (such as⁎ Corresponding author. Fax: +1 301 827 0440.
E-mail address: jesse.goodman@fda.hhs.gov (J.L. Goodman).
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doi:10.1016/j.ygeno.2006.06.002FADD or TRADD), and an initiator caspase such as
procaspase 8 [7]. Clustering of death receptors promotes
aggregation of procaspase 8 within DISC and induces
autoproteolysis and generation of active caspase 8, further
activates downstream effector caspase 3. In the intrinsic
pathway, the caspase cascade is initiated by mitochondrial
depolarization and release of proapoptotic factors such as
cytochrome c. The apoptosome, a complex analogous to
DISC, is formed when cytochrome c associates with Apaf-1
and procaspase 9. Subsequently, caspase 9 is activated on the
apoptosome and further activates downstream caspase 3 [8].
The extrinsic pathway can provide apoptotic signaling
upstream of the intrinsic pathway through caspase 8-mediated
cleavage of a Bcl-2 family protein, Bid, which inserts into the
mitochondrial membrane and induces cytochrome c release
[9]. Some suggest that mitochondria initiate neutrophil
apoptotic signaling [5]. Others suggest that clustering of
death receptors in lipid rafts initiates neutrophil spontaneous
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apoptosis is caspase 8 dependent [10,11]. To determine the
mechanisms of Ap-induced antiapoptosis, we used oligonu-
cleotide microarrays to compare very early changes in gene
expression in Ap-infected neutrophils. The expression of
genes involved in both extrinsic and intrinsic apoptotic
regulatory pathways was confirmed by real-time PCR analysis
and by protein caspase activity assays. Multiple genes were
found to be up-regulated after 1–3 h of Ap infection,
consistent with global inhibition of apoptosis.
Results
Ap infection causes delay in apoptosis of human neutrophils
Neutrophil apoptosis was assessed by Giemsa staining and
caspase activity assays. Ap infection induced a marked delay
in neutrophil apoptosis with a reduction in apoptotic
neutrophils from 79.2 ± 5.1 to 39.9 ± 5.0% at 20 h. This
reduction of apoptosis by Ap was accompanied by corre-
sponding 42.7 ± 3.1 and 33.3 ± 5.9% reductions in caspase 3
and 8 activity, respectively.
Modulation of apoptosis-related genes by Ap in neutrophils
Highly purified neutrophils were infected with Ap or mock
infected for various periods of time; total RNA was extracted
and subjected to microarray hybridization and data analysis.
Thirty-seven genes potentially related to apoptosis were found
to be reproducibly up-regulated at least twofold within 3 h of
Ap infection of neutrophils (Table 1).These include 23
antiapoptotic genes (e.g., BCL2A1) and 5 genes (e.g., BID)
associated with apoptosis.
To confirm gene expression results by microarray, QRT-
PCR analysis was performed for antiapoptotic genes. As
shown in Table 1, the expression of five randomly selected
antiapoptotic genes was confirmed to be up-regulated by both
microarray and QRT-PCR analyses. Thus, an excellent
correlation between both microarray and QRT-PCR analyses
was observed.
In contrast to numerous up-regulated genes, a limited
number of genes was found to be down-regulated in Ap-
infected neutrophils (Table 2).Down-regulated genes included,
among others, the proapoptotic genes CARD10, TAIP2, and
SMAD7. Down-regulation of these genes may lead to delayed
apoptosis. CARD10 contains a caspase recruitment domain,
interacts with BCL10, is involved in NFKB signaling
complexes, and induces apoptosis. TAIP2 is a TGF-β-induced
apoptosis protein. SMAD7 interacts with β-catenin in a TGF-
β-dependent manner. Physical association of SMAD7 β-
catenin was found to be important for TGF-β-induced
apoptosis [12]. Several apoptosis-related genes, such as
TNFRSF1A, CAPN1, and PIK3CB, were also down-regu-
lated in Ap-infected HL-60 cells (data not shown). Both
TNFRSF1A and CAPN1 are proapoptotic genes. TNFRSF1A
is a member of the TNF-receptor superfamily that activates
NF-κB and mediates apoptosis [13]. CAPN1 (calpain 1) is acalcium activated, nonlysosomal, intracellular cysteine pro-
tease that regulates Bax and subsequent Smac-dependent
caspase-3 activation in neutrophil apoptosis [14].
Ap-induced apoptotic gene expression in HL-60 cells
In contrast to neutrophils, Ap-infected HL-60 cells do not
undergo delayed apoptosis. In fact, some studies have
reported that HL-60 cells became apoptotic after Ap infection
[15,16]. We performed microarray analysis on Ap-infected
HL-60 cells at 2, 8, and 22 h (Table 3). Up-regulated genes
seen in both Ap-infected neutrophils and HL-60 cells early
following infection included NF κB-related genes (NFKBIA,
NFKBIE), cytokines and chemokines (IL1B, IL8, CCL4), and
a limited number of apoptosis-related genes (such as BCL3
and PPP1R15A). However, major differences between Ap-
infected neutrophils and HL-60 cells were found in the
expression of apoptosis regulatory genes. Several major
antiapoptotic neutrophil genes that were up-regulated in Ap-
infected neutrophils were not up-regulated in Ap-infected HL-
60 cells (Tables 1 and 3). These genes include BCL2A1,
GADD45B, HIF1A, PIM2, CFLAR, IER3, and CD44. Thus,
antiapoptosis in neutrophils is accompanied by cell-type-
specific changes in the regulatory pathways inhibiting
apoptosis.
Discussion
By microarray technology we have defined the early
molecular events involved in Ap-induced neutrophil anti-
apoptosis. Together with the resultant reduction in caspase 8
activity, we show that both extrinsic (TNFAIP3, CFLAR,
SOD2) and intrinsic (BCL2A1, PIM2, BIRC3) pathways of
apoptosis are profoundly affected by Ap infection of
neutrophils. Multiple signaling pathways orchestrate a com-
plex cascade of events resulting in a global antiapoptotic state
and the survival of neutrophils, a prerequisite for this obligate
intracellular parasite. Fig. 1A shows the network of pathways
in which the up-regulated antiapoptotic genes are involved.
For the intrinsic pathway, BCL2A1, a member of the BCL2
family, is up-regulated (confirmed and quantitated by RT-PCR
as a 29-fold increase). BCL2A1 sequesters truncated Bid to
inhibit collaboration with proapoptotic Bak or Bax and reduce
cytochrome c release from mitochondria, blocking caspase
activation. BCL2A1 up-regulation during Ap infection was
also recently reported by Ge et al. [17]. PIM2, up-regulated
3.7-fold at 3 h, is involved in the intrinsic pathway as a
serine/threonine kinase that phosphorylates Bad and reverses
Bad-induced cell death [18]. For the extrinsic pathway, FLIP,
the gene product of CFLAR, is up-regulated by Ap (1.6-fold
at 1 h and 6-fold at 8 h postinfection, Table 1). CFLAR acts
as an inhibitor of Fas-, TNFR-, and TRAIL-mediated
apoptosis. Its proteolytic fragment (p43) is retained in DISC
and blocks further recruitment, processing, and activation of
caspase 8 [19].
Cytokines (IL1B, PBEF1) and chemokines (IL8, CXCL1)
were among the most up-regulated transcripts (Table 1).
Table 1










1 h d 3 h d 8 h e
IL8 NM_000584 2.8 15.0 6.2 Interleukin 8 A20 13.1
IL1B NM_000576 10.4 10.1 1.8 Interleukin 1, β A20 140.0
BCL2A1 NM_004049 2.8 8.6 3.2 BCL2-related protein A1 A17 29.9
GADD45B NM_015675 2.3 7.7 4.1 Growth arrest and DNA-damage-inducible, β A22 13.1
CCL4 NM_002984 2.7 6.7 4.7 Chemokine (C-C motif) ligand 4 A25
SOD2 NM_000636 2.8 6.2 11.7 Superoxide dismutase 2, mitochondrial A23 3.3
CXCL1 NM_001511 5.4 4.6 2.7 Chemokine (C-X-C motif) ligand 1




NM_003998 1.1 4.5 4.2 Nuclear factor of κ light polypeptide gene enhancer
in B cells 1 (p105)
A
PBEF1 NM_005746 2.0 4.4 – f Pre-B-cell colony enhancing factor 1 A21
DUSP1 NM_004417 3.9 4.4 1.7 Dual-specificity phosphatase 1
HIF1A NM_001530 1.7 4.3 3.9 Hypoxia-inducible factor 1, α subunit A25
NFKBIA
(IKBA)
NM_020529 4.1 4.2 1.8 Nuclear factor of κ light polypeptide gene enhancer
in B cells inhibitor, α (MAD3)
PIM2 NM_006875 2.1 3.7 2.8 Pim-2 oncogene A18
PRKCD NM_212539 1.7 3.7 2.0 Protein kinase C, δ
TNF NM_000594 – f 3.6 1.3 Tumor necrosis factor (TNF superfamily, member 2; TNF-α) A/P
RASGRF1 NM_153815 1.6 3.6 1.4 Ras protein-specific guanine nucleotide–releasing factor 1
IER3 NM_052815 3.0 3.5 5.9 Immediate early response 3 A
STAT5A NM_003152 1.6 3.5 2.1 Signal transducer and activator of transcription 5A
MAP2K3 NM_145109 1.8 3.2 1.4 Mitogen-activated protein kinase kinase 3 A24, 28
CD44 NM_000610 1.6 3.1 2.1 CD44 antigen A
NFKBIE
(IKBE)
NM_004556 2.2 3.1 3.1 Nuclear factor of κ light polypeptide gene enhancer
in B cells inhibitor, ε
HNRPC NM_004500 1.3 3.1 2.3 Heterogeneous nuclear ribonucleoprotein C (C1/C2) A
CDKN1A NM_078467 1.3 3.0 6.0 Cyclin-dependent kinase inhibitor 1A (p21Cip1) A
GRIPAP1 NM_020137 1.9 3.0 2.8 GRIP1-associated protein 1
AXUD1 NM_033027 3.0 3.0 1.2 AXIN1 up-regulated 1 (TAIP-3) P
NFKB2 NM_002502 1.9 2.9 1.7 Nuclear factor of κ light polypeptide gene enhancer in B cells 2 (p49/p100) A
ICAM1 NM_000201 1.4 2.8 1.3 Intercellular adhesion molecule 1 (CD54) A
DUSP2 NM_004418 3.5 2.8 3.0 Dual-specificity phosphatase 2
PPP1R15A NM_014330 2.5 2.6 – f Protein phosphatase 1, regulatory (inhibitor) subunit 15A (GADD34) P
CFLAR NM_003879 1.6 2.5 6.1 CASP8 and FADD-like apoptosis regulator (FLIP) A19
SPHK1 NM_182965 1.8 2.5 1.8 Sphingosine kinase 1 A
BCL3 NM_005178 2.0 2.3 – f B cell CLL/lymphoma 3
BIRC3 NM_001165 2.2 2.2 – f Baculoviral IAP repeat-containing 3 (cIAP2) A
CD14 NM_000591 1.5 2.2 2.7 CD14 antigen A
TNFAIP3 NM_006290 4.6 2.1 – f Tumor necrosis factor, α-induced protein 3 (A20) A
BID NM_197967 1.3 2.1 4.1 BH3_interacting domain death agonist (BID) P
TANK NM_004180 1.1 2.0 5.2 TRAF family member-associated NF-κB activator P
a Genes included are 2-fold or greater up-regulated at 3 h and are listed in order of level of increase at 3 h. Fold change greater than 3 has a confidence interval of
99%. Fold change greater than 2 has a confidence interval of 90%.
b P, proapoptotic; A, antiapoptotic Numbers in superscript represent publications describing apoptotic character of these genes.
c Mean of three repeats comparing samples of Ap-infected and mock-infected PMNs after 3 h incubation. The PCR primers and the sizes of the amplicons
were as follows: IL8, Forward, 5′-GGTTGTGGAGAAGTTTTTGA; Reverse, 5′-CAGACCCACACAATACATGA; 135 bp; IL1B, Forward, 5′-
AATGACAAAATACCTGTGGC; Reverse, 5′-TCCATCTTCTTCTTTGGGTA; 131 bp; BCL2A1, Forward, 5′-CCAGGCAGAAGATGACAG; Reverse, 5′-
CTGGCAGTGTCTACGGAC; 214 bp; GADD45B, Forward, 5′-AGAAGATGCAGACGGTGA; Reverse, 5′-TCTGGGTCCACATTCATC; 115 bp; SOD2,
Forward, 5′-GTTGGCTTGGTTTCAATAAG; Reverse, 5′-ACTGAAGGTAGTAAGCGTGC; 135 bp; GAPDH, Forward, 5′-AAGGTGAAGGTCGGAGTC;
Reverse, 5′-GGTCAATGAAGGGGTCAT; 112 bp. All primer sets, except for BCL2A1, were designed to span one or more introns. Electrophoretic analysis
of expected product sizes was performed for all primer sets prior to QPCR to confirm the fidelity of the reaction.
d Mean of three biological repeats with similar general fold increase is presented.
e Data from a single microarray experiment.
f Data not available.
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neutrophil apoptosis in both autocrine and paracrine fashions
[20,21]. Interestingly, pre-B-cell colony-enhancing factor
(PBEF1), a novel inflammatory cytokine that plays a
requisite role in delaying neutrophil apoptosis, was upmore than fourfold in neutrophils within 3 h of Ap
infection. Prevention of PBEF1 translation with an antisense
oligo has been shown to abrogate the inhibitory effects of
LPS, IL-1, GM-CSF, IL-8, and TNF-α on neutrophil
apoptosis [21].
Table 2







FRAT1 NM_005479 3.8 Frequently rearranged in advanced
T cell lymphomas
MPO NM_000250 2.2 Myeloperoxidase
ADPRH NM_001125 2.1 ADP-ribosylarginine hydrolase
3 h b
ELP4 NM_019040 4.0 Elongation protein 4 homolog
(Saccharomyces cerevisiae)
CARD10 NM_014550 2.5 Caspase recruitment domain family,
member 10
TAIP2 NM_024969 2.4 TGF-β-induced apoptosis protein 2
ATP2B3 NM_001001344 2.2 ATPase, Ca2+-transporting, plasma
membrane 3
SMAD7 NM_005904 2.0 SMAD, mothers against DPP
homolog 7 (Drosophila)
8 h c
USP16 NM_001001992 3.5 Ubiquitin-specific peptidase 16
FGF1 NM_000800 3.3 Fibroblast growth factor 1 (acidic)
MATN1 NM_002379 3.2 Matrilin 1, cartilage matrix protein
VRK1 NM_003384 3.2 Vaccinia-related kinase 1
PPARD NM_006238 3.0 Peroxisome proliferative activated
receptor, δ
a Genes included are 2-fold or greater down-regulated at 1 or 3 h and 3-fold or
greater down-regulated at 8 h. Fold change greater than 3 has a confidence
interval of 99%. Fold change greater than 2 has a confidence interval of 90%.
b Mean of three biological repeats with similar general fold decrease is
presented.
c Data from a single microarray experiment.
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MAPKs, ERKs, PI3K, AKT, and JNK, contributing to
antiapoptosis were up regulated by Ap infection of neutro-
phils (Fig. 1B). NF κB (up-regulated 4.5 fold at 3 h) may
play a central role not only by inducing the expression of
several survival proteins (BCL2A1, SOD2, CDKN1A, and
HIF1A), but also by suppressing the proapoptotic JNK
pathway through blocking MKK7 catalytic activity by
inducing GADD45B [22], elevated >7-fold at 3 h. SOD2,
an NF κB-inducible manganese superoxide dismutase, may
also protect some transformed cells from TNF-α-induced
apoptosis, presumably through clearance of reactive oxygen
species (ROS) [23]. Therefore, reduction of ROS by up-
regulation of SOD2 (increased 11.7-fold at 8 h) may be one
of several Ap strategies to delay neutrophil apoptosis.
Furthermore, p38MAPK phosphorylates and inhibits both
caspase 3 and caspase 8 and delays neutrophil apoptosis [24].
Recently, CCL4 was identified as a neutrophil survival factor,
under the control of hypoxia-inducible factor 1 α (HIF1A)
[25]. CCL4 is increased 6.7- and 4.7-fold 3 and 8 h after Ap
infection, respectively (Table 1). Induction of CCL4 by
HIF1A (also significantly up-regulated) may be part of an
autocrine/paracrine antiapoptotic mechanism.
Borjesson et al. [26] suggest that Ap fails to trigger the
neutrophil proapoptotic program induced by typical bacterial
pathogens and suggested, consistent with our findings, that Apmay inhibit Fas-induced apoptosis. Compared to our studies,
they identified a more limited number of up-regulated
antiapoptotic genes 3 h after Ap infection, although at 24 h
they noted additional genes found by us to be up-regulated
within 3 h. The earlier detection of antiapoptotic gene
expression in the present studies most likely reflects a higher
efficiency and synchronicity of infection but could also reflect
differences in the microarray platforms. Consistent with our
findings of early and global antiapoptosis, a recent study by
Sukumaran et al. [27] noted early (4 h) up-regulation of several
of the antiapoptotic genes we report here, including BCL2A1,
BIRC3, GADD45B, SOD2, and CFLAR. Our studies have
identified several additional potentially important antiapoptotic
genes and pathways that are up-regulated, including PIM2,
HIF1A, PBEF1, and IER3 [27]. In addition, we show that
antiapoptotic genes (SOD2, CFLAR, IER3) maintained their
high levels of expression (greater than sixfold) even 8 h after Ap
infection. Finally, we also have shown that many of the
antiapoptotic genes up-regulated by Ap infection of primary
neutrophils are not affected during infection of HL-60 cells,
suggesting cell-type-specific effects (Table 3).
Previous studies have shown that heat-killed Ap can delay
neutrophil apoptosis but to a lesser extent than viable
infectious Ap [6,26]. Moreover, recent studies have shown
that active intracellular growth of Ap inside human
neutrophils may contribute to and further enhance a delay
in apoptosis [28]. Since our goal was to map efficiently and
understand fully the molecular biology of Ap infection-
induced antiapoptosis, we employed live Ap in our studies so
that the level of gene expression would be optimized and the
full scope of involved pathways discovered.
In conclusion, we report that Ap delays neutrophil
spontaneous apoptosis by rapidly and persistently affecting
both extrinsic and intrinsic apoptotic pathways through
activation of multiple redundant signaling pathways. Choi et
al. [28] showed that p38MAPK is phosphorylated and
activated very early in Ap-infected neutrophils and this
initial activation of the p38MAPK pathway leads to delayed
neutrophil apoptosis. However, early activation of the
p38MAPK pathway can be bypassed within 3 to 6 h of
active intracellular Ap infection [28]. Thus, multiple path-
ways are activated and are likely required during various
stages of the intracellular Ap infection to maintain the
prolonged antiapoptotic state that is likely needed to allow
bacterial survival and replication in neutrophils that otherwise
would rapidly apoptose. Further evaluation of the phosphor-
ylation status and expression levels of the gene products of
interest identified in our studies may be helpful in determin-
ing the relative contributions of the involved pathways.Materials and methods
Neutrophil isolation and infection
Human peripheral blood neutrophils (polymorphonuclear neutrophils) were
isolated from EDTA-anticoagulated blood of normal donors as approved by the
Research Involving Human Subjects Committee of the FDA. Neutrophils were
Table 3






Protein or gene Fold change in
HL-60 cells b
2 h c 8 h d 22 h d
IL8 NM_000584 Interleukin 8 3.2 3.3 2.2
IL1B NM_000576 Interleukin 1, β 6.3 3.8 2.7
BCL2A1 ⁎ NM_004049 BCL2-related protein A1 1.3 1.1 1.3
GADD45B ⁎ NM_015675 Growth-arrest and
DNA-damage-inducible, β
–1.1 1.0 1.5
CCL4 NM_002984 Chemokine (C-C motif)
ligand 4
2.9 2.4 1.6
SOD2 ⁎ NM_000636 Superoxide dismutase 2,
mitochondrial
1.2 2.0 1.8
CXCL1 ⁎ NM_001511 Chemokine (C-X-C motif)






NM_003998 Nuclear factor of κ light
polypeptide gene enhancer
in B cells 1 (p105)
1.6 2.8 1.1
PBEF1 ⁎ NM_005746 Pre-B-cell colony
enhancing factor 1
1.2 2.0 1.9
DUSP1 ⁎ NM_004417 Dual-specificity
phosphatase 1
1.3 1.0 –1.2





NM_020529 Nuclear factor of κ light
polypeptide gene enhancer
in B cells inhibitor, α
(MAD3)
3.2 3.7 2.5
PIM2 ⁎ NM_006875 Pim-2 oncogene 1.6 1.5 1.3
PRKCD ⁎ NM_212539 Protein kinase C, δ 1.5 1.3 1.6




RASGRF1 ⁎ NM_153815 Ras protein-specific guanine
nucleotide-releasing factor 1
1.2 1.1 1.1
IER3 ⁎ NM_052815 Immediate early response 3 1.7 –1.1 1.6
STAT5A ⁎ NM_003152 Signal transducer and
activator of transcription 5A
1.5 –1.5 –1.6
MAP2K3 ⁎ NM_145109 Mitogen-activated protein
kinase kinase 3
1.5 1.1 1.4
CD44 ⁎ NM_000610 CD44 antigen (homing





NM_004556 Nuclear factor of κ light
polypeptide gene enhancer in
B cells inhibitor, ε
2.1 1.8 2.4
HNRPC ⁎ NM_004500 Heterogeneous nuclear
ribonucleoprotein C (C1/C2)
1.3 1.6 1.3
CDKN1A ⁎ NM_078467 Cyclin-dependent kinase
inhibitor 1A (p21Cip1)
1.4 1.5 1.3
GRIPAP1 ⁎ NM_020137 GRIP1-associated protein 1 1.4 1.7 1.5
AXUD1 ⁎ NM_033027 AXIN1 up-egulated 1
(TAIP3)
–1.3 1.1 1.0
NFKB2 NM_002502 Nuclear factor of κ light
polypeptide gene enhancer
in B cells 2 (p49/p100)
2.0 4.3 2.1
ICAM1 ⁎ NM_000201 Intercellular adhesion
molecule 1 (CD54), human
rhinovirus receptor
(ICAM1)
1.4 1.3 – e






Protein or gene Fold change in
HL-60 cells b
2 h c 8 h d 22 h d




CFLAR ⁎ NM_003879 CASP8 and FADD-like
apoptosis regulator (FLIP)
1.1 –1.1 –1.1
SPHK1 ⁎ NM_182965 Sphingosine kinase 1 1.3 1.2 1.6
BCL3 NM_005178 B cell CLL/lymphoma 3 2.3 2.7 1.7
BIRC3 NM_001165 Baculoviral IAP
repeat-containing 3 (cIAP2)
1.7 4.5 1.9
CD14 ⁎ NM_000591 CD14 antigen –1.2 1.1 1.2
TNFAIP3 NM_006290 Tumor necrosis factor,
α-induced protein 3 (A20)
3.0 4.1 2.3
BID ⁎ NM_197967 BH3-interacting domain
death agonist (BID)
1.0 1.5 1.7




a The same set of genes shown to have been modulated in neutrophils
(Table 1) is included.
b Negative values are fold of decrease.
c Mean of four biological repeats.
d Mean of two biological repeats.
e Data not available.
⁎ Genes up–regulated in Ap–infected neutrophils but not in Ap–infected HL-
60 cells.
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washed twice in phosphate-buffered saline (1 × DPBS; GIBCO, Carlsbad, CA,
USA), resuspended in RPMI 1640 medium (GIBCO) supplemented with 10%
fetal bovine serum (FBS; HyClone, Logan, UT, USA) and 2 mM L-glutamine
(GIBCO), and counted using a hemacytometer. Purity was >95% by Giemsa
staining. Ap strain HGE2 was propagated in HL-60 cells as described [2].
Heavily Ap-infected (>90%) HL-60 cells (5 × 107 cells or 5 × 107 uninfected
HL-60 cells for mock infection) were used to prepare cell-free bacteria [29].
Cell-free Ap and mock-infected preparations were immediately used to infect
neutrophils (2 × 107 cells) at a high multiplicity of infection (25–50 bacteria/
cell). Both Ap-and mock-infected neutrophils were cultured in RPMI 1640
supplemented with 10% FBS at 37°C in 5% CO2. Apoptosis and infection were
monitored by Giemsa staining. HL-60 cells (2 × 107) were also infected with
cell-free Ap-or mock-infected preparations as described above and cultured in
RPMI 1640 supplemented with 10% FBS at 37°C in 5% CO2 for 2, 8, or 22 h to
evaluate Ap effects on gene expression in HL-60 cells.
Microarray analysis
Microarray fabrication, probe hybridization/washing, and data analysis were
performed as described [30,31] following the MIAME (minimum information
about a microarray experiment) guidelines.
Microarray fabrication
The human microarrays containing approximately 17,000 oligonucleotides
were fabricated on poly-L-lysine-coated glass slides using an OmniGrid
microarrayer (GeneMachine, San Carlos, CA, USA). The human genome
oligonucleotides were purchased from Operon/Qiagen. Each oligo is a 70-mer
that was selected from 750 nucleotides of the 3′ end of the ORF. Detailed
information regarding the coating of glass slides with poly-L-lysine, printing
of oligonucleotides on the slides, and postprocessing of the printed slides is
presented at the Web site of the Advanced Technology Center, National
Cancer Institute (http://nciarray.nci.nih.gov/reference).
Fig. 1. A. phagocytophilum inhibits human neutrophil apoptosis through multiple molecular pathways. (A) A. phagocytophilum infection affects both the extrinsic
(death receptor) and the intrinsic (mitochondrial) apoptotic pathways in human neutrophils. Genes shown to be up-regulated by our microarray studies (Table 1) are
underlined. (B) A. phagocytophilum inhibits neutrophil apoptosis through multiple signaling pathways. Genes shown to be up-regulated (Table 1) are underlined.
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Total RNA fromAp-infected and mock-infected neutrophils was extracted 1,
3, or 8 h postinfection using Trizol (Invitrogen, Carlsbad, CA, USA) according
to the manufacturer's protocol.
Probe preparation and purification
Total RNA (5 μg) from mock-infected or Ap-infected neutrophils was
reverse transcribed and labeled with Cy3 or Cy5 (Amersham Biosciences Corp.,Piscataway, NJ, USA), respectively. Total RNA (12 μl) was incubated at 70°C
for 5 min along with 1 μl modified oligo(dT) and quickly chilled for 3 min. The
7-μl reaction mixture containing 2 μl 10× first-strand buffer, 1.5 μl 20× aa–
dUTP/dNTP (10 mM dATP, 10 mM dGTP, 10 mM dCTP, 6 mM dTTP, and
4 mM aminoallyl–dUTP), 2 μl 0.1 M DTT, and 1.5 μl Stratascript RT
(Stratagene) was added to the RNA–primer mix and incubated at 42°C for
60 min. After incubation, MinElute PCR purification kits were used to purify the
cDNA; dH2O was added to make up to a total volume of 60 μl. Then, 300 μl of
PB binding buffer (Qiagen MinElute PCR Purification Kit) was added to the
mixture, loaded on a MinElute column, and spun for 1 min at maximum speed.
Flowthrough was discharged and the column was washed twice with PE
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eluted by adding 15 μl elution buffer to the center of the column and incubation
for 2 min, followed by centrifugation at maximum speed for 1 min. The eluate
was dried by Speed-Vac for 14 to 15 min.
Dye coupling and purification
cDNA pellet was resuspended into 5 μl 2× coupling buffer (0.2 M NaHCO3,
pH 9.0). Five-microliter aliquots of Cy3 or Cy5 dye was mixed well by pipetting
(final concentration of coupling reaction 0.1 M NaHCO3, pH 9.0; total reaction
10 μl) and then placed in a dark box at room temperature for 60 min. After
coupling, 50 μl dH2O was added to the mixture, and then 300 μl PB buffer was
added. Labeled cDNA was purified on a MinElute column as described above
except the cDNA was eluted in 10 μl of elution buffer. After elution, Cy3-and
Cy5-labeled cDNA probes were combined and adjusted to final volume of 25 μl
with dH2O.
Hybridization and washing
A total of 25 μl of purified cDNA was mixed with 1 μl (1 μg) poly(dA)
(Amersham Pharmacia Biotech), 1 μl (1 μg) Cot-1 human DNA (Invitrogen),
1 μl (4 μg) yeast tRNA (Invitrogen), 1 μl 10% SDS, and 6 μl 20× SSC to a total
volume of 35 μl. The probe was denatured for 2 min at 100°C and then added on
the array slide and covered with a coverslip (22 × 40 mm). The slide was placed
in a hybridization chamber and hybridized at 65°C for 16–18 h. After
hybridization, array slides were washed with 2× SSC with 0.1% SDS for 2 min,
1× SSC for 3 min, and finally 0.2× SSC for 2 min at room temperature. Slides
were quickly spin-dried before scanning.
Image acquisition and data analysis
Slides were scanned in both Cy3 and Cy5 channels on a GenePix 4000B
scanner (Axon Instruments, Inc., Foster City, CA, USA)with a 10-μm resolution.
Scanned microarray images were exported as TIFF files to GenePix Pro 5.0
software for image analysis. The raw images were collected at 16-bit/pixel
resolutions that displayed all pixels in a 0 to 65,535 count dynamic range. Images
and data were analyzed through the grid generated from the GenePix Array List
(GAL) file. The GAL file was consolidated through GeneMachines OmniGrid
arrayer software after printing. Data files were imported into mAdb (microarray
database: http://nciarray.nci.nih.gov/) and analyzed by the software tools
provided by the Center for Information Technology at the National Institutes
of Health. The advanced filters that were applied before data analysis fulfilled the
following requirements: spot size at least 30 μm,minimum fluorescence intensity
of 200 in both Cy3 and Cy5 channels, ratio of signal over background at least 2.0
in both channels. These advanced filters prevented the potential effect of poor-
quality spots in data analysis. A standard global normalization approachwas used
for each experiment. All of the extracted data were normalized using a 50th
percentile (median) normalization method available through the mAdb database.
Real-time RT-PCR
Up-regulation of selected antiapoptotic genes was confirmed and quantitated
by two-step real-time quantitative RT-PCR using GAPDH as a normalizer.
Relative quantitation was performed with StrataScript reverse transcriptase and
Brilliant SYBR Green QPCR Master Mix on a Stratagene Mx3000P real-time
PCR system (Stratagene, La Jolla, CA, USA). RNA (200 ng) was reverse-
transcribed and 1/50 of the reaction used in SYBR QPCR (95°C, 10 min; 50
cycles of 95°C for 30 s, 55°C for 60 s, 72°C for 60 s).
Caspase activity assays
Caspase 3 and 8 activity assays were performed according to instructions
(R&D Systems, Minneapolis, MN, USA). Briefly, equal numbers of Ap- or
mock-infected neutrophils (2 × 106 cells) were harvested after 20 h by
centrifugation at 250 g for 10 min. Supernatant was removed and each cell
pellet was lysed by the addition of 50 μl cold lysis buffer. The cell lysate wasincubated on ice for 10 min and then centrifuged at 10,000 g for 1 min to
remove debris. Fifty microliters of either 2× Reaction Buffer 3 or 2× Reaction
Buffer 8 was added to 50 μl of cell lysate (Buffer 3 was for the caspase 3
assay, whereas Buffer 8 was for the caspase 8 assay) and 5 μl of caspase
colorimetric substrate (either DEVD –pNA for caspase 3 or IETD –pNA for
caspase 8) was added to initiate the reaction. The reaction mixture was
incubated at 37°C for 2 h and absorbance was read at 405 nm wavelength.
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